Innovative MedTech Makes Strategic Shift in Business Direction to the AI Sports and Entertainment Industry

BLUE ISLAND, IL - June 2, 2025 (NEWMEDIAWIRE) - Innovative MedTech, Inc. (the "Company") (OTC: IMTH), a provider of health and wellness services, today announced that it has entered into an agreement to acquire certain assets of Ticketbash, a ticket servicing company for live events. Ticketbash had 2024 revenues of approximately $7.6 Million Dollars (unaudited) and has recently developed proprietary AI software that is expected to bring much-needed transparency and cost efficiency to the ticket industry.

"This asset acquisition is very exciting for the Company, as it marks a bold and strategic move into the flourishing sports, entertainment and media sectors. In connection with this asset acquisition, we are reviewing several attractive options for our healthcare businesses, including a sale of our SarahCare subsidiaries and a potential spin-off of our Oral Thrush product. Although we strongly believe in these businesses, they do not fit with our strategic shift into the AI sports and entertainment platforms and the amazing growth opportunities we are targeting therein," said Michael Friedman, CEO of Innovative MedTech.

He continued, "Acquiring Ticketbash should open a whole host of new possibilities for us, as we gain traction with Ticketbash's proprietary AI platform - a scalable technology already transforming ticketing operations. The move should position the Company at the forefront of applying advanced AI to build new business models and reach new markets faster than ever before. We, with Ticketbash, are already negotiating service deals with some of the up-and-coming giants in the sports industry and are also actively looking into several significant acquisition and joint venture opportunities."

Integration efforts are already underway to expand the AI platform's applications into both existing and new verticals. Additionally, the Company intends to file for a name and symbol change to reflect the new business.

Key Transaction Terms and Details

Pursuant to the Asset Purchase Agreement between the parties, Ticketbash agreed to sell to the Company certain of their assets (i.e., their AI software and related IP), and on May 30, 2025, and because of existing encumbrances on the assets being sold, the Company and Ticketbash entered into an amendment to the purchase agreement (the "Amendment"), providing that (i) the Company would pay $1,000,000 to Ticketbash within 10 months (the "Initial Cash Payment"), and upon completion of the Initial Cash Payment, the purchased assets will be immediately transferred to the Company; (ii) the Company will immediately issue Ticketbash's owners a number of shares of Company preferred stock having voting rights equal to sixty percent (60%) of the total voting rights of the Company, and which shares of preferred stock shall have no economic rights, except that such shares shall automatically convert into sixty percent (60%) of the total number of outstanding shares of Company common stock on a fully diluted basis (following issuance of conversion shares) calculated as of June 1, 2025, upon the payment by the Company of the Initial Cash Payment; (iii) an additional $2,000,000 cash payment shall be paid by the Company over a 36-month period based on based on revenue and income milestones to be determined by the parties in the future, and (iv) future royalties shall be paid to Ticketbash based on aggregate revenues generated by the Company's new Ticketbash subsidiary as follows: 2% of revenue up to $15,000,000, 4% of revenue from $15,000,000-$25,000,000, and 5% of revenue in excess of $25,000,000.